FDA Approved: IMATINIB — Supplemental Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for imatinib from Dr. Reddy's Laboratories, supporting an update to the drug's labeling under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Dermatofibrosarcoma Protuberans
• Gastrointestinal Stromal Tumor
• Hypereosinophilic Syndrome

Drugs mentioned

• Imatinib (imatinib)

Snippet

SUPPL AP for IMATINIB (IMATINIB)